Bank Mandiri (Persero) has seen its Fair Value Estimate rise modestly, climbing from IDR 5,439 to IDR 5,467 as analyst optimism grows. The improved price target is the result of upgraded expectations about government liquidity support and the bank's strengthened market position. Stay tuned to discover ways to monitor these evolving insights and remain informed on the latest narrative shifts affecting Bank Mandiri's stock.
Stay updated as the Fair Value for Bank Mandiri (Persero) shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Bank Mandiri (Persero).
What Wall Street Has Been Saying
Recent analyst commentary highlights growing optimism around Bank Mandiri (Persero)'s outlook, though some reservations remain among the more cautious voices.
🐂 Bullish Takeaways
-
Goldman Sachs analyst Melissa Kuang upgraded PT Bank Mandiri to Buy from Neutral and set a new price target of IDR 5,850.
-
The firm expects Bank Mandiri to benefit from the government's announced liquidity injection into deposits, which should reinforce the bank's liquidity position and support its ongoing growth momentum.
-
The upgrade reflects increased confidence in the bank's execution and its ability to harness policy support.
🐻 Bearish Takeaways
-
Despite the upgrade, the initial Neutral rating from Goldman Sachs points to earlier concerns regarding valuation and the degree to which upside prospects may already be reflected in the current share price.
Overall, recent analyst research, particularly from Goldman Sachs, underscores the market's recognition of Bank Mandiri's robust positioning and liquidity tailwinds. However, some caution persists around valuation and priced-in optimism.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!
What's in the News
-
PT Bank Mandiri (Persero) Tbk has scheduled a Special/Extraordinary Shareholders Meeting for December 19, 2025, which may indicate potential strategic announcements or key decisions on the horizon.
-
The bank continues to benefit from positive analyst sentiment after an upgraded price target and a Buy rating from Goldman Sachs, following improved liquidity support from the government.
-
Market observers are watching closely to see how Bank Mandiri makes use of its strengthened position in the competitive Indonesian banking sector and adapts to evolving regulatory conditions.
How This Changes the Fair Value For Bank Mandiri (Persero)
-
The Fair Value Estimate has increased slightly from IDR 5,439 to IDR 5,467, reflecting an improved outlook.
-
The Discount Rate has decreased modestly from 14.53% to 14.21%, which indicates reduced perceived risk.
-
The Revenue Growth projection has dipped from 12.16% to 11.89%, suggesting slightly more conservative future growth expectations.
-
The Net Profit Margin forecast has edged up from 31.98% to 32.21%, pointing to improved profitability assumptions.
-
The Future Price-to-Earnings (P/E) ratio has declined marginally from 12.07x to 12.03x, which signals small changes in market valuation expectations.
🔔 Never Miss an Update: Follow The Narrative
A Narrative is a user-friendly way to connect a company's real-world story to financial forecasts and fair value estimates. On Simply Wall St, millions of investors use Narratives on the Community page to see beyond the numbers by combining their perspectives about a company's future with quantitative forecasts. Narratives let you compare Fair Value to current Price, update automatically as news unfolds, and help make timing buy or sell decisions easier than ever.
Follow the original narrative on Bank Mandiri (Persero) to stay in the loop as the story develops:
-
Track how government liquidity measures are expected to drive loan growth, revenue, and sector resilience for Bank Mandiri.
-
See why digital banking investments and a focus on low-cost funding could boost margins and long-term profitability.
-
Stay aware of key risks, including rising funding costs and macroeconomic pressures, that may impact earnings and valuation outlooks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BMRI .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
